IXCHIQ
2025/CHU/12
Approved mab active
Quick answer
IXCHIQ for Chikungunya Virus Infection is a Approved program (mab) at ARS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARS Pharmaceuticals
- Indication
- Chikungunya Virus Infection
- Phase
- Approved
- Modality
- mab
- Status
- active